20B507

Atopic dermatitis (eczema)

 20-507 Part B, £3,700 + reasonable travel expenses

People with moderate to severe atopic dermatitis (eczema) needed for the study of a potential new treatment to treat the condition. You must be 18 to 65 years old; Vegetarians and smokers are allowed. The study involves 2 screening visits, 1 session of 3 nights’ residence on our wards, 2 sessions of 1 night’s residence, and 13 outpatient visits over approximately 5 months. Trial ongoing throughout 2022.